Literature DB >> 11576235

Regression of peritoneal leiomyomatosis after treatment with gonadotropin releasing hormone analogue.

P.A. Clavero1, F.F. Nogales, I. Ruiz-Avila, J. Linares, A. Concha.   

Abstract

A case of a 42-year-old woman with peritoneal leiomyomatosis (PL) unrelated to pregnancy or any other obvious hormonal source is presented. After treatment with leuprolide acetate for six months, a second-look operation revealed that the majority of the nodules totally regressed. The few remaining ones were substantially reduced in size and exhibited histopathologic evidence of fibrotic change. This response to treatment is documented here for the first time. Since this case was not associated with initial abnormally raised hormonal levels, the regression was caused solely by the treatment and not by the removal of any hormonal stimulus. The usefulness of GnRH analogues in the treatment of PL is proposed.

Entities:  

Year:  1992        PMID: 11576235     DOI: 10.1046/j.1525-1438.1992.02010052.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  2 in total

1.  [Leiomyomatosis peritonealis disseminata and borderline lesion].

Authors:  V Lubczyk; A du Bois; A Fisseler-Eckhoff
Journal:  Pathologe       Date:  2005-07       Impact factor: 1.011

2.  Leiomyomatosis peritonealis disseminata associated with endometriosis and multiple uterus-like mass: report of two cases.

Authors:  Filomena M Carvalho; Jesus Paula Carvalho; Ricardo Mendes Alves Pereira; Benito Pio Vitório Ceccato; Rafael Lacordia; Edmund Chada Baracat
Journal:  Clin Med Insights Case Rep       Date:  2012-05-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.